KIF14 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.961550E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.853000E-01
Normal-vs-Stage2
1.648200E-01
Normal-vs-Stage3
6.157600E-01
Normal-vs-Stage4
2.702600E-01
Stage1-vs-Stage2
4.288800E-01
Stage1-vs-Stage3
6.749800E-01
Stage1-vs-Stage4
5.509200E-01
Stage2-vs-Stage3
2.774400E-01
Stage2-vs-Stage4
9.239000E-01
Stage3-vs-Stage4
4.023600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.019800E-01
Normal-vs-AfricanAmerican
1.627200E-01
Normal-vs-Asian
1.750040E-01
Caucasian-vs-AfricanAmerican
8.656200E-01
Caucasian-vs-Asian
4.593600E-01
AfricanAmerican-vs-Asian
6.157000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.115800E-01
Normal-vs-Female
1.818050E-01
Male-vs-Female
7.767600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
9.818200E-01
Normal-vs-Age(41-60Yrs)
1.781010E-01
Normal-vs-Age(61-80Yrs)
2.121200E-01
Normal-vs-Age(81-100Yrs)
1.426950E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.741840E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.059600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.501630E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
4.200400E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.032800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.483600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.507200E-01
Normal-vs-Daily Drinker
3.025600E-01
Normal-vs-Weekly Drinker
1.977440E-01
Normal-vs-Occasional Drinker
1.914170E-01
Normal-vs-Social Drinker
2.377600E-01
Non Drinker-vs-Daily Drinker
5.998000E-01
Non Drinker-vs-Weekly Drinker
9.184600E-01
Non Drinker-vs-Occasional Drinker
4.957400E-01
Non Drinker-vs-Social Drinker
6.577200E-01
Daily Drinker-vs-Weekly Drinker
5.673200E-01
Daily Drinker-vs-Occasional Drinker
2.649600E-01
Daily Drinker-vs-Social Drinker
3.876400E-01
Weekly Drinker-vs-Occasional Drinker
6.203000E-01
Weekly Drinker-vs-Social Drinker
7.629400E-01
Occasional Drinker-vs-Social Drinker
8.669000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
7.586000E-01
Normal-vs-Grade 2
9.308600E-01
Normal-vs-Grade 3
6.195400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.991000E-04
Grade 1-vs-Grade 3
1.96343999999682E-05
Grade 1-vs-Grade 4
7.586000E-01
Grade 2-vs-Grade 3
6.353700E-02
Grade 2-vs-Grade 4
9.308600E-01
Grade 3-vs-Grade 4
6.195400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.998200E-01
Normal-vs-NonDiabetic
1.685150E-01
Diabetic-vs-NonDiabetic
1.302050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.081030E-01
Normal-vs-NoPancreatitis
2.293000E-01
Pancreatitis-vs-NoPancreatitis
9.952200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
1.975640E-01
Normal-vs-N1
1.824980E-01
N0-vs-N1
8.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.443900E-02
Normal-vs-TP53-NonMutant
2.414000E-01
TP53-Mutant-vs-TP53-NonMutant
4.26189999958027E-07
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
